Anu works in our Immunovirology and Pathogenesis Program as a Senior Research Associate and life scientist. She explores the beautiful, complex world of viruses and strategies they adopt to survive and thrive in their environment. #ScienceWeek
Sarah is a Senior Lecturer & leader of the Clinical, Experimental and Computational Immunology Group, which conducts research into infectious & inflammatory diseases & looks to develop new treatments for these conditions, or to optimise the use of existing therapies. #ScienceWeek
OUT NOW👉Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
By Turville & colleagues @StuartTurville@KirbyInstitute@UNSWMedicine@UNSW
read it here: https://t.co/MrqjCEREos
https://t.co/WWE6nHlYFe
1- Closing off of the 2021 variant chapter from the team's perspective. We only had so many hands and we needed to find simple and cost-effective solutions where we could scale
https://t.co/8XWBMlcykW #behindthepaper@StuartTurville@KirbyInstitute@UNSWMedicine@UNSW
In 2021 we made tools to rapidly capture & analyse live SARS CoV2 variants. To rank them for evasion to antibodies we used antibodies pooled from thousands of convalescent/ vaccinated donors. In late November we isolated the first Omicron case in a Australia. Here is its rank
@RNDrive@UNSW@tanya_plibersek @eliza_owen @Alicia_Barry @JulesBoykoff Thank you so much for your time to talk about our work and it’s role in Covid response. Here is Omicron in action eating it’s way through our engineered cells we have made to catch it and future variants. I’ll post a movie but if another variant to see what is happening here.
Professor Tony Kelleher, director of the Kirby Institute says that data shows #AstraZeneca was just as good as other vaccines when it came to what mattered most — preventing hospitalisation and severe disease.
https://t.co/UwShiJ4ZBO
This week’s podcast is a compilation of some of the best conversations I’ve had on the podcast about movement.
In this clip, @kellymcgonigal discusses whether exercise can be a path to self-fulfillment and connection 👉🏾 https://t.co/ITI0FmwNQV
More than a decade after the first efficacy evidence for #PrEP was reported, PrEP uptake globally has been inadequate and global #HIV prevention targets have been missed. Scaling up PrEP is crucial to achieving the UNAIDS prevention targets for 2030. https://t.co/1B8RTrSeID
For many, the pandemic has forced us to change the way we work. This includes researchers behind the scenes who are constantly trying to keep up with the SARS-CoV-2 virus. This is a day in the life of an immunologist @StuartTurville@KirbyInstitute@UNSW
https://t.co/5iRDLQHLt4
Next week, we welcome Prof Nikolai Petrovsky, Vaxine Pty Ltd & @Flinders. He will be talking about the general landscape of biodefense vaccine development, incl. progress of Vaxine’s Covax-19, the only active 🇦🇺 clinical-stage #COVID19 vaccine candidate. https://t.co/rxccnYDdux